Health News


Women who undergo IVF pregnancy are at no greater risk of contracting breast cancer, according to researchers at Center for Human Reproduction at North Shore University Hospital in Manhasset, New York. The study collected health records from 25,000 women and found no "significant increase in the long-term risk of breast cancer among women treated with these IVF regimens."
PEGIViolence-072116.jpg Parents should be wary of their children's exposure to violence in the media, according to a new study from researchers at the American Academy of Pediatrics (AAP). According to the new statement, there is a clear and traceable connection between the amount of violence kids take in from the media and increased aggressive behavior. "With children, actual physical violence is, thankfully, rare."
Jesus-is-So-Cool-062316.jpg There are risks associated with getting a tattoo, according to the U.S. Food and Drug Administration. There are increasing reports of people developing infections from contaminated tattoo inks and having bad reactions to the inks, according to Dr. Linda Katz, director of the FDA's Office of Cosmetics and Colors. More
A new experimental drug for postpartum depression quickly eased women's symptoms with no side effects and no remission, according to a preliminary study. Sage Therapeutics reports that 70 percent of women treated with the drug SAGE-547 experienced relief from postpartum depression within 60 hours of starting treatment and saw the benefits of the drug continue for at least 30 days. The practice of pubic hair grooming may be growing more popular amongst younger women, according to a new study from researchers the University of California, San Francisco Medical Center. They found the phenomenon especially true for women in their 20s, white women and those who attended college. Pelvic exams may not provide any additional benefit for many women, according to a new study from researchers at the The United States Preventive Services Task Force. The group released a new statement this week noting that there is not enough strong evidence to suggest that women should undergo the costly and uncomfortable procedure. More

Nearly Half Of All Sunscreens Don't Protect Against The Sun

Nearly one-half of all sunscreen products in the U.S. fail to meet basic sun safety guidelines, according to a new study. For the study, published in the journal JAMA Dermatology, researchers reviewed the safety labeling of Amazon's top-reviewed sunscreens, 65 products that accounted for the top one percent of all sunscreens sold by Amazon.com.

Drug Resistant Gonorrhea On The Rise

The number of drug resistant cases of gonorrhea have increased in the U.S. in recent years, according to a new study from researchers at the Centers for Disease Control and Prevention. The agency released an official statement earlier this week noting that "the future of current treatment options may be in jeopardy."

Pokémon Go Could Help Those With Mental Illness Feel Better

Use of the wildly popular new gaming app Pokemon Go may help people with mental illness feel better, according to a new study from researchers at Media Psychology Research Center in Newport Beach, California. According to the Center's report, users that are otherwise largely sedentary and bound to the indoors may be getting more exercise and social interaction than normal because of the game.

Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
10/22/16MDVNXTANDI (sNDA)FDA decision on XTANDI in metastatic castration-resistant prostate cancer with data from head-to-head studies of Enzalutamide Vs Bicalutamide
10/22/16OPKRAYALDEE (NDA Resubmission)FDA decision on RAYALDEE for the treatment of secondary hyperparathyroidism in adult patients with stage 3 or 4 CKD and vitamin D insufficiency.
10/19/16RHHBYAtezolizumab (BLA)FDA decision on Atezolizumab for the treatment of specific type of lung cancer
10/19/16AGNSER120 (low-dose desmopressin nasal spray) NDAFDA panel to review SER120 for the treatment of adult onset nocturia
10/18/16NICXF.PKAC-170 (NDA)FDA decision on AC-170 for the treatment of ocular itching associated with allergic conjunctivitis
10/14/16EGLTARYMO ER (NDA)FDA decision on ARYMO ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data